Michele is an Associate Principal at RBB Economics, based in Milan. He holds an MSc in Economics and Social Sciences from Bocconi University in Milan. Since joining RBB Economics in 2019, Michele has advised on a wide range of competition matters before the European Commission and several national competition authorities and tribunals, including in Italy, the UK, Australia and South Africa.
Michele has advised clients on competition aspects before the European Commission and numerous national competition authorities, including the Competition and Market Authority (CMA) in the UK, the Australian Competition and Consumer Commission (ACCC) in Australia and the Competition Commission in South Africa.
His experience includes merger investigations raising both horizontal and non-horizontal concerns as well as abuse of dominance, vertical agreements, cartels, and follow-on damage assessments. Michele has also assisted in the preparation of expert economic evidence in different competition law proceedings in front of courts in Italy, the UK and South Africa. In addition, Michele has assisted clients with the implementation of the “Digital Market Act” (DMA).
Michele has provided economic advice across a wide range of sectors, including the automotive and train sector, the pharmaceutical industry, different insurance markets, medical imaging, the market of medical databases, cloud computing, the dental industry, the port industry and the LPG market.
Michele has contributed to the last four editions of The Economic Assessment of Mergers under European Competition Law (Cambridge University Press, 2013).
Selected Cases
-
Oracle/Cerner
Merger, EU
-
Siemens Healthineers/Varian
Merger, Global
-
Alstom/Bombardier
Merger, Global
-
EEX/Nasdaq Power
Merger, EU
-
Bayer/Elanco
Merger, EU
-
Sodra
Cartel investigation, EU
-
Oil sector abuse of dominance arbitration
Abuse of dominance & Arbitration, Italy
-
Amazon
Digital Markets Act, EU
A global network of experienced experts
Our 260-strong, multi-lingual team, spread across 16 offices, has managed over 3,000 cases in 120+ countries, advising on more than one-third of EU Phase II cases in the last 5 years.